Research Snapshot
Mechanism & Biological Context
Selank and Semax are synthetic peptide analogues studied through distinct and incompletely characterized neurobiological pathways. Proposed effects involve neurotrophic, monoaminergic, immune, and stress-response signaling, but mechanisms and clinically relevant exposure-response relationships remain unsettled.
A plausible pathway is not the same as a demonstrated clinical outcome. Mechanistic, animal, and human findings are labeled separately.
Human Evidence
Human literature exists for each compound, but much is older, small, region-specific, or difficult to generalize. Direct controlled evidence for the combined Selank-plus-Semax product is especially limited.
Male & Female Research
The male and female centers present the same evidence tier because convincing sex-specific efficacy has not been established. The site highlights study representation and evidence gaps instead of assigning gendered claims.
What Is Not Established
The combination is not established to treat anxiety, depression, ADHD, cognitive impairment, stroke, or traumatic brain injury. Product purity, formulation, route, and equivalence to research preparations are major uncertainties.
Approval, legality, formulation, and indication are compound-specific. A research product, COA, or published mechanism does not establish medical suitability.
Primary References
Revision History
Expanded with sex-specific interpretation, regulatory status, evidence limitations, and primary-source references.